Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: PerkinElmer and Celmatix Clinical Laboratories

NEW YORK (GenomeWeb) – PerkinElmer this week declared a regular quarterly dividend of $.07 per share of common stock, payable on May 10 to all shareholders of record at the close of business on April 14.

The New Jersey Economic Development Authority (EDA) this week announced that digital health technology firm Celmatix Clinical Laboratories has opened its new lab at the EDA's Commercialization Center for Innovative Technologies (CCIT), the state's life sciences incubator. The CCIT is a 75-acre life sciences research park that provides tenants with labs pace, educational programs, and support resources, the EDA said.

In Brief This Week is a selection of news items that may be of interest to our readers but had not previously appeared on the GenomeWeb site.